Alessandra Punziano

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study.

High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study.

Journal: Journal of clinical immunology
Published: November 14, 2023

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID).

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID).

Journal: Frontiers in immunology
Published: July 12, 2023

BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.

BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.

Journal: Viruses
Published: July 05, 2023

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.

Journal: Frontiers in immunology
Published: June 28, 2023

Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.

Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.

Journal: Frontiers in immunology
Published: May 30, 2023

A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes.

A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes.

Journal: Frontiers in immunology
Published: November 08, 2022

Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study.

Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study.

Journal: Journal of clinical immunology
Published: August 23, 2022

Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic.

Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic.

Journal: Frontiers in immunology
Published: May 18, 2022

Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy.

Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy.

Journal: Biomedicines
Published: March 10, 2022

The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet).

The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet).

Journal: Journal of clinical immunology
Published: November 15, 2021

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies.

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies.

Journal: Cells
Published: September 16, 2021

Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.

Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.

Journal: JAMA network open
Published: June 10, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026